Literature DB >> 8764090

Neutralizing antibodies to different proteins of African swine fever virus inhibit both virus attachment and internalization.

P Gómez-Puertas1, F Rodríguez, J M Oviedo, F Ramiro-Ibáñez, F Ruiz-Gonzalvo, C Alonso, J M Escribano.   

Abstract

African swine fever virus induces in convalescent pigs antibodies that neutralized the virus before and after binding to susceptible cells, inhibiting both virus attachment and internalization. A further analysis of the neutralization mechanisms mediated by the different viral proteins showed that antibodies to proteins p72 and p54 are involved in the inhibition of a first step of the replication cycle related to virus attachment, while antibodies to protein p30 are implicated in the inhibition of virus internalization.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8764090      PMCID: PMC190536     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  Characterization of foot-and-mouth disease virus gene products with antisera against bacterially synthesized fusion proteins.

Authors:  K Strebel; E Beck; K Strohmaier; H Schaller
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

2.  Localization of structural proteins in African swine fever virus particles by immunoelectron microscopy.

Authors:  J L Carrascosa; P González; A L Carrascosa; B Garciá-Barreno; L Enjuanes; E Viñuela
Journal:  J Virol       Date:  1986-05       Impact factor: 5.103

Review 3.  African swine fever virus.

Authors:  E Viñuela
Journal:  Curr Top Microbiol Immunol       Date:  1985       Impact factor: 4.291

4.  Purification and iodination of antibody for use in an immunoradiometric assay for serum ferritin.

Authors:  L M Gonyea
Journal:  Clin Chem       Date:  1977-02       Impact factor: 8.327

Review 5.  African swine fever: a reassessment.

Authors:  W R Hess
Journal:  Adv Vet Sci Comp Med       Date:  1981

6.  Analysis of the complete nucleotide sequence of African swine fever virus.

Authors:  R J Yáñez; J M Rodríguez; M L Nogal; L Yuste; C Enríquez; J F Rodriguez; E Viñuela
Journal:  Virology       Date:  1995-04-01       Impact factor: 3.616

7.  Two-dimensional analysis of African swine fever virus proteins and proteins induced in infected cells.

Authors:  A Esteves; M I Marques; J V Costa
Journal:  Virology       Date:  1986-07-15       Impact factor: 3.616

8.  The entry of African swine fever virus into Vero cells.

Authors:  A Alcamí; A L Carrascosa; E Viñuela
Journal:  Virology       Date:  1989-07       Impact factor: 3.616

9.  Inhibition of African swine fever infection in the presence of immune sera in vivo and in vitro.

Authors:  F Ruiz Gonzalvo; M E Carnero; C Caballero; J Martínez
Journal:  Am J Vet Res       Date:  1986-06       Impact factor: 1.156

10.  Neutralization of African swine fever virus by sera from African swine fever-resistant pigs.

Authors:  F Ruiz Gonzalvo; C Caballero; J Martinez; M E Carnero
Journal:  Am J Vet Res       Date:  1986-08       Impact factor: 1.156

View more
  47 in total

1.  Hemagglutinin 1-specific immunoglobulin G and Fab molecules mediate postattachment neutralization of influenza A virus by inhibition of an early fusion event.

Authors:  M J Edwards; N J Dimmock
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

2.  Optimization and validation of recombinant serological tests for African Swine Fever diagnosis based on detection of the p30 protein produced in Trichoplusia ni larvae.

Authors:  D M Pérez-Filgueira; F González-Camacho; C Gallardo; P Resino-Talaván; E Blanco; E Gómez-Casado; C Alonso; J M Escribano
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

3.  African swine fever virus structural protein pE120R is essential for virus transport from assembly sites to plasma membrane but not for infectivity.

Authors:  G Andrés; R García-Escudero; E Viñuela; M L Salas; J M Rodríguez
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

4.  An African swine fever virus ERV1-ALR homologue, 9GL, affects virion maturation and viral growth in macrophages and viral virulence in swine.

Authors:  T Lewis; L Zsak; T G Burrage; Z Lu; G F Kutish; J G Neilan; D L Rock
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

5.  Phenotype-based identification of host genes required for replication of African swine fever virus.

Authors:  Annie C Y Chang; Laszlo Zsak; Yanan Feng; Ronen Mosseri; Quan Lu; Paul Kowalski; Aniko Zsak; Thomas G Burrage; John G Neilan; Gerald F Kutish; Zhiqiang Lu; Will Laegreid; Daniel L Rock; Stanley N Cohen
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

6.  Different mechanisms of antibody-mediated neutralization of parvoviruses revealed using the Fab fragments of monoclonal antibodies.

Authors:  Christian D S Nelson; Laura M Palermo; Susan L Hafenstein; Colin R Parrish
Journal:  Virology       Date:  2007-01-09       Impact factor: 3.616

7.  The major structural protein of African swine fever virus, p73, is packaged into large structures, indicative of viral capsid or matrix precursors, on the endoplasmic reticulum.

Authors:  C Cobbold; T Wileman
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

8.  African swine fever virus protein p54 interacts with the microtubular motor complex through direct binding to light-chain dynein.

Authors:  C Alonso; J Miskin; B Hernáez; P Fernandez-Zapatero; L Soto; C Cantó; I Rodríguez-Crespo; L Dixon; J M Escribano
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

9.  The cryo-EM structure of African swine fever virus unravels a unique architecture comprising two icosahedral protein capsids and two lipoprotein membranes.

Authors:  German Andrés; Diego Charro; Tania Matamoros; Rebecca S Dillard; Nicola G A Abrescia
Journal:  J Biol Chem       Date:  2019-10-24       Impact factor: 5.157

10.  Antigenic properties and diagnostic potential of African swine fever virus protein pp62 expressed in insect cells.

Authors:  Carmina Gallardo; Esther Blanco; Javier M Rodríguez; Angel L Carrascosa; Jose Manuel Sanchez-Vizcaino
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.